Exosome injections for common male hair loss
Part of Skin clinical trials.
This trial tests whether injecting exosomes, tiny particles from cells, into the scalp can help regrow hair in men with common male pattern baldness. It's an early-stage study that also looks at how the treatment affects hair follicles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man with noticeable hair loss at the top or front of your head, ranging from mild to moderate (grades 1-4).
- You do not have any blood disorders or blood-related diseases.
- You are not currently receiving other treatments for hair loss or any other condition.
- You have no history of cancer or allergic reactions to exosomes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding exosomes (tiny cell-repair particles) to a fractional laser treatment helps regrow hair more effectively than laser alone in men with common pattern baldness. If you qualify, you'll receive treatment on part of your scalp while doctors compare both approaches.
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
This trial compares different in-office procedures (like injections, lasers, or platelet-rich plasma) to treat male pattern hair loss. It aims to find which method works best to help hair grow back or stop thinning. Participation could provide access to new treatments that target the root cause of hair loss.
This trial compares two treatments—secretome and platelet-rich plasma (PRP)—to see which helps grow thicker, denser hair in people with genetic hair loss (androgenetic alopecia). It's for adults aged 25 to 59 who have stopped taking certain hair loss medications for at least a month.
This trial tests an investigational treatment called XVIE, given as an injection into the scalp, to see if it can help people with male or female pattern hair loss. It may be an option for those who have had stable hair loss for at least six months and are not currently using other hair loss treatments.
This study tests whether microneedling (a procedure using tiny needles on the scalp) can safely help regrow hair in men with male pattern baldness. Participants will receive the procedure and be monitored over time with scalp photos.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.